tanezumab Articles
US surveyed PCPs and pain specialists experienced reimbursement restrictions for Janssen's Nucynta ER
28 August 2012
Another Pfizer pain drug candidate flops, as firm suspends tanezumab clinical trial program
20 July 2010
Showing 1-5 of 5 articles
- 1
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
